Edward James Bass Net Worth & Insider Trades
Edward James Bass - Director, Reata Pharmaceuticals Inc
What is Edward James Bass's Net Worth?
The current estimated net worth of Reata Pharmaceuticals Inc's Director, Edward James Bass, is estimated to be about $1.74M . Edward James Bass owns about 53,605 units of Reata Pharmaceuticals Inc common stock. In the last 4 years at Reata Pharmaceuticals Inc, Edward James Bass has sold an estimated value of $586.92K worth.
What is Edward James Bass's Past Insider Trading?
Edward James Bass's largest purchase order was 30,488 units , worth over $264.4K on June 2, 2016. Edward James Bass's largest sale order was 8,483 units , worth over $586.92K on March 7, 2019. In total, Edward James Bass has made about 14 transactions over 4 years of their time at Reata Pharmaceuticals Inc. Edward James Bass usually trades in June, with the busiest year in 2018 and 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Edward James Bass
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Edward James Bass's' Mailing Address?
- Mailing address is C/o Reata Pharmaceuticals, Inc. 2801 Gateway Dr. Suite 150 Irving TX 75063 TX
Reata Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|
| J. Warren Huff | 2020 | $636,400 | $413,660 | - | $5,000 | $5,000 | $6,396,130 |
| J. Warren Huff | 2019 | $578,500 | $600,540 | - | $16,715 | $16,715 | $5,542,605 |
| J. Warren Huff | 2018 | $534,000 | $400,500 | - | - | - | $934,500 |
| Manmeet S. Soni | 2020 | $545,900 | $445,700 | - | $136,125 | $136,125 | $4,465,894 |
| Manmeet S. Soni | 2019 | $179,385 | $408,873 | - | $70,243 | $70,243 | $12,261,587 |
| Dawn C. Bir | 2020 | $422,000 | $239,900 | - | $5,000 | $5,000 | $3,871,542 |
| Dawn C. Bir | 2019 | $375,100 | $287,550 | - | $3,500 | $3,500 | $1,975,899 |
| Colin J. Meyer, M.D. | 2020 | $513,951 | $381,400 | - | - | - | $4,233,520 |
| Colin J. Meyer, M.D. | 2019 | $445,600 | $389,467 | - | - | - | $2,182,780 |
| Colin J. Meyer, M.D. | 2018 | $417,000 | $208,500 | - | - | - | $625,500 |
| Michael D. Wortley | 2020 | $421,100 | $339,500 | - | - | - | $3,965,242 |
| Michael D. Wortley | 2019 | $382,800 | $341,400 | - | - | - | $2,033,949 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm
What are Reata Pharmaceuticals Inc's Past Insider Trades?
Reata Pharmaceuticals Inc's most recent insider trade came on September 18, 2023 by Andrea Loewen who sold 3,175 units worth $546.18K . In the last 7 years, insiders at Reata Pharmaceuticals Inc have sold an estimated value of $178.68M and bought an estimated value of $141.88M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are R. Kent McGaughy Jr., Douglas Jason Wilson, Executive VP Operations, and Elaine Castellanos, VP .
REATA PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||